Labeler · US market
Incyte Corporation
Incyte Corporation is a US drug labeler with US FDA registrations covering 7 drug concepts (7 currently active) across 26 packages. It is currently the only active US supplier of 7 drugs.
ACTIVE — US
openFDA · updated weekly
Labeler codes50881 · 73535
Active drugs7
Registrations22 active / 22
Packages26
Sole supplier of7 drugs
Portfolio7 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Ruxolitinib tablet | rx | 5 | 6 | SUPPLYING |
| Ruxolitinib tablet, extended release | rx | 5 | 5 | SUPPLYING |
| Axatilimab-Csfr injection | rx | 5 | 5 | SUPPLYING |
| Ruxolitinib cream | rx | 1 | 4 | SUPPLYING |
| Pemigatinib tablet | rx | 3 | 3 | SUPPLYING |
| Tafasitamab-Cxix injection, powder, lyophilized, for solution | rx | 2 | 2 | SUPPLYING |
| Retifanlimab-Dlwr injection | rx | 1 | 1 | SUPPLYING |
Pill